Onconetix Inc. shares soared 23.65% after hours following clinical progress updates, new study initiation and developments in prostate cancer diagnostics.
Importance Rank:
1
Onconetix Inc. shares soared 23.65% after hours following clinical progress updates, new study initiation and developments in prostate cancer diagnostics.
© MegaHoot, LLC. All Rights Reserved | media at hootdex.com | Privacy Policy | Risk Disclosure | Legal Disclaimer | TOS | Neutrality | AML/KYC
